Reviva Pharmaceuticals Holdings, Inc. (RVPH) has gained Thursday morning, with the stock adding 9.23% in pre-market trading to 4.26. RVPH's short-term technical score of 41 indicates that the stock has traded less bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 104 out of 146 industries, the stock ranks higher than 56% of stocks. Reviva Pharmaceuticals Holdings, Inc. has fallen 10.34% over the past month, closing at $3.81 on February 29. During this period of time, the stock fell as low as $2.76 and as high as $4.07. RVPH has an average analyst recommendation of Strong Buy. The company has an average price target of $18.25.
RVPH has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on RVPH!